The University of Washington received $10 million from billionaires Charles and Lisa Simonyi to launch an initiative ...

Discover why Recursion Pharmaceuticals, Inc. stands out in AI drug discovery, but faces valuation risks. Click for my look at ...

Futures for the Dow Jones Industrial Average and other major stock indexes traded squarely lower in premarket action as the ...

The founder of Amazon and Blue Origin is stepping into his first operational role at a company since 2021 at AI start-up ...

Startups are using AI to streamline not only component design but also the subsequent manufacturing phase. CaDDi Inc., which ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

AI breakthroughs in pharma are pushing Eli Lilly and healthcare stocks higher—and may soon reshape how we fight cancer.

Jeff Bezos, the founder of Amazon and one of the world’s wealthiest people, is throwing his money and time into an artificial ...

For rare diseases, AI-driven repurposing fills a critical gap. With more than 7000 rare diseases and only a small percentage ...

Quiq reports on key questions surrounding AI, covering its capabilities, risks, ethical challenges, and future implications ...

Pfizer is launching the first clinical trials for its PD-1xVEGF drug, while Akeso detailed the first overall survival win for ...